ALPMYASTELLAS PHARMA/ADR

$13.23
$0.31
(2.29%)
Today
Closed $13.23
$0.006
(0.04%)
After Hours
Updated: 04:00 PM EDT
EarningsJul 30
Mkt Cap$24.26B
Vol189,768.00
News
all
press releases
Is Astellas Pharma (ALPMY) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
News Placeholder
More News
News Placeholder
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?
Here is how Astellas Pharma Inc. (ALPMY) and Aurinia Pharmaceuticals (AUPH) have performed compared to their sector so far this year.
Zacks
News Placeholder
Is OCGN Stock Worth the Risk Ahead of 2026-27 Eye Gene Therapy Data?
Ocugen faces cash burn and dilution risks, but upcoming eye gene therapy data and planned filings through 2027 could shape its next phase.
Zacks
News Placeholder
MRK Stock Gains After CHMP Backs Keytruda Combo for Bladder Cancer
Merck jumps after CHMP backs Keytruda plus Padcev for certain bladder cancer patients, a combo with the potential to expand treatment options.
Zacks
News Placeholder
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?
Here is how Astellas Pharma Inc. (ALPMY) and BillionToOne (BLLN) have performed compared to their sector so far this year.
Zacks
News Placeholder
Are Medical Stocks Lagging Arcellx (ACLX) This Year?
Here is how Arcellx, Inc. (ACLX) and Astellas Pharma Inc. (ALPMY) have performed compared to their sector so far this year.
Zacks
News Placeholder
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?
Here is how Astellas Pharma Inc. (ALPMY) and Adlai Nortye Ltd. Sponsored ADR (ANL) have performed compared to their sector so far this year.
Zacks
News Placeholder
Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year?
Here is how Astellas Pharma Inc. (ALPMY) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Zacks
News Placeholder
Japan’s Astellas Pharma hits 8-mth high on upbeat Q1 earnings
Investing.com-- Shares of Astellas Pharma Inc. (TYO:4503) jumped to an eight-month high on Thursday after the Japanese drugmaker reported robust first-quarter earnings, driven by strong sales of key cancer treatments and cost-cutting measures.
investing.com
News Placeholder
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
Here is how Abbott (ABT) and Astellas Pharma Inc. (ALPMY) have performed compared to their sector so far this year.
Zacks
<
1
2
...
>

Advertisement|Remove ads.